Psychiatry

no

Psychiatry

Psychiatry is the medical specialty devoted to the assessment, diagnosis, treatment, and prevention of mental disorders. Clinically, Psychiatry integrates biomedical and psychosocial knowledge to evaluate disturbances in mood, cognition, perception, motivation, behaviour, and personality across the lifespan. Psychiatrists complete medical school and residency training, practice in community and hospital settings, and provide a full range of interventions, including psychotherapy, psychopharmacology, and neuromodulation (e.g., electroconvulsive therapy and transcranial magnetic stimulation). Because the focus keyword Psychiatry is widely used by health systems, universities, and journals, its scope spans basic neuroscience, clinical medicine, public health, ethics, and law.

Psychiatry
Also called	Psychological medicine; mental health medicine
Focus	Mental, emotional, behavioural, and neurodevelopmental disorders
Training	Medical degree (MD/DO/MBBS) → Residency (3–6 years) → Subspecialty fellowships
Interventions	Psychotherapy • Psychopharmacology • Neuromodulation (ECT, TMS) • Collaborative & community care
Subspecialties	Child & adolescent • Geriatric • Addiction • Forensic • Consultation–liaison • Emergency • Neuropsychiatry • Perinatal • Sleep • Pain
Related fields	Clinical psychology • Neurology • Family medicine • Public health • Neuroscience • Social work
Key classifications	DSM-5-TR • ICD-11
Professional orgs	American Psychiatric Association • Royal College of Psychiatrists • World Psychiatric Association

Etymology and definitions

The term derives from Greek psyche (soul/mind) and iatreia (healing). Modern Psychiatry is grounded in medicine and attends to the **biopsychosocial** context of illness—biological mechanisms (genes, brain circuits, physiology), psychological processes (cognition, emotion, learning), and social determinants (relationships, culture, environment). Psychiatrists differ from clinical psychologists in **medical training**, authority to prescribe medications in most jurisdictions, and scope for somatic treatments and hospital practice; in many systems the professions collaborate closely.

Historical overview

Early traditions and moral treatment

Ancient medical texts described melancholia, mania, and hysteria, with Greco-Roman physicians (e.g., Hippocrates, Galen) proposing humoral and brain-based hypotheses. Medieval and early modern approaches ranged from spiritual care to confinement. In the late 18th and early 19th centuries, **moral treatment**—associated with Philippe Pinel and William Tuke—advocated humane care and structured environments, prefiguring modern psychosocial rehabilitation.

Nosology and early biological psychiatry

By the late 19th century, nosologists such as Emil Kraepelin classified syndromes (e.g., manic–depressive illness, dementia praecox) and emphasised prognosis and course. Sigmund Freud’s psychoanalysis introduced systematic psychotherapeutic theories and methods. Parallel neuropathological work linked general paresis of the insane (neurosyphilis) to infection, demonstrating that some mental illnesses have specific biological causes.

Psychopharmacology, deinstitutionalisation, and community care

The mid-20th century saw effective medications—chlorpromazine (antipsychotic), imipramine (tricyclic antidepressant), lithium (mood stabiliser), and benzodiazepines—transforming treatment and enabling **deinstitutionalisation** toward community-based services. Behaviour therapies and later cognitive–behavioural therapies diversified psychosocial care.

Contemporary developments

Late 20th–early 21st century Psychiatry integrates neurobiology (imaging, genetics), evidence-based psychotherapy, population health, and person-centred recovery. Diagnostic systems evolved from DSM-III’s operational criteria to DSM-5-TR and ICD-11; transdiagnostic frameworks (e.g., NIMH RDoC) and computational psychiatry explore mechanisms beyond surface categories.

Classification and diagnostic frameworks

Most clinical systems rely on **DSM-5-TR** (North America) and **ICD-11** (global) for diagnostic criteria. Categories are organised by symptomatic clusters, course, and impairment. Clinicians combine **structured clinical interviews**, **mental status examination**, functional assessment, and collateral information. Debate continues over reliability, validity, and cultural generalisability of categories; dimensional models (e.g., internalising/externalising spectra) and staging approaches are increasingly used.

Major grouping (DSM-5-TR/ICD-11)	Examples
Neurodevelopmental	Autism spectrum disorder; ADHD; intellectual disability; tic disorders
Schizophrenia spectrum & other psychotic	Schizophrenia; schizoaffective disorder; delusional disorder
Bipolar and related	Bipolar I/II disorder; cyclothymic disorder
Depressive	Major depressive disorder; persistent depressive disorder
Anxiety	Generalised anxiety; panic disorder; phobias; agoraphobia
Obsessive–compulsive and related	OCD; body dysmorphic disorder; hoarding disorder; trichotillomania
Trauma- and stressor-related	PTSD; acute stress disorder; adjustment disorders
Dissociative	Dissociative identity disorder; depersonalisation/derealisation
Somatic symptom and related	Somatic symptom disorder; illness anxiety disorder; conversion disorder
Feeding and eating	Anorexia nervosa; bulimia nervosa; binge-eating disorder
Elimination	Enuresis; encopresis
Sleep–wake	Insomnia; narcolepsy; obstructive sleep apnoea; circadian rhythm disorders
Sexual dysfunctions & gender-related	Erectile disorder; female sexual interest/arousal disorder; gender dysphoria
Disruptive, impulse-control, conduct	Oppositional defiant; intermittent explosive; conduct disorder
Substance-related & addictive	Alcohol use disorder; opioid use disorder; gambling disorder
Neurocognitive	Delirium; major/mild neurocognitive disorder (dementias)
Personality	Borderline; antisocial; avoidant; obsessive–compulsive personality disorders

Epidemiology and global burden

Mental disorders are common, often chronic or recurrent, and contribute substantially to years lived with disability (YLDs). Comorbidity among psychiatric, neurological, and medical conditions is the rule rather than exception; social determinants (poverty, trauma, discrimination) shape risk, course, and access to care. **Global mental health** initiatives emphasise task-sharing, culturally adapted care, and integration into primary health systems.

Psychiatric assessment

Assessment combines medical and psychosocial perspectives:

• **History and interview**: presenting problems; chronology; past psychiatric, medical, substance, and family histories; developmental and sociocultural context; strengths and goals.
• **Mental status examination (MSE)**: appearance/behaviour, speech, mood/affect, thought process/content, perception, cognition, insight/judgment.
• **Risk assessment**: suicide and violence risk; capacity to consent; safeguarding and support needs.
• **Physical and neurological exam** with targeted labs or imaging to exclude medical causes (e.g., thyroid dysfunction, seizures).
• **Standardised measures**: symptom and functioning scales (e.g., PHQ-9, GAD-7), cognitive screening (e.g., MoCA), diagnostic interviews when indicated.
• **Cultural formulation** and shared decision-making to align care with values and beliefs.

Treatment approaches

Modern Psychiatry adopts evidence-based, person-centred, and recovery-oriented care, often through **collaborative care** models linking primary care and specialty teams.

Psychopharmacology

Therapeutic classes include:

• **Antidepressants** (SSRIs, SNRIs, TCAs, MAOIs, multimodal agents) for depressive and anxiety disorders.
• **Mood stabilisers** (lithium, valproate, carbamazepine, lamotrigine) for bipolar spectrum and augmentation.
• **Antipsychotics** (first- and second-generation) for schizophrenia spectrum disorders and mood episodes with psychosis.
• **Anxiolytics** (benzodiazepines, pregabalin), **hypnotics**, and **stimulants** for specific indications.
• **Adjunctive/novel agents**: ketamine/esketamine for treatment-resistant depression; pimavanserin for Parkinson psychosis; clozapine for refractory schizophrenia; alpha-2 agonists for tics/ADHD; VMAT2 inhibitors for tardive dyskinesia and chorea.

Medication decisions weigh efficacy, tolerability, interactions, monitoring needs (e.g., clozapine agranulocytosis, lithium levels), pregnancy/lactation considerations, and patient preferences.

Psychotherapies

A wide range of psychotherapies—delivered by psychiatrists and allied professionals—have strong evidence bases:

• **CBT** for depression, anxiety, OCD, psychosis (with adaptations).
• **Interpersonal psychotherapy (IPT)** for depression and perinatal mood disorders.
• **Dialectical behaviour therapy (DBT)** for borderline personality disorder and self-harm.
• **Family-based therapies** (e.g., for early psychosis and adolescent eating disorders).
• **Psychodynamic therapies** for personality and complex presentations.
• **Acceptance and commitment therapy (ACT)** and other contextual behavioural approaches.

Combined treatment (psychotherapy + medication) often yields superior outcomes for moderate-to-severe conditions.

Neuromodulation and somatic therapies

• **Electroconvulsive therapy (ECT)** is highly effective for severe major depression, catatonia, and treatment-resistant mania/psychosis; modern anaesthetised techniques reduce risks.
• **Repetitive transcranial magnetic stimulation (rTMS)** is approved for treatment-resistant depression and OCD variants; **theta-burst** protocols shorten sessions.
• **Vagus nerve stimulation (VNS)** and **deep brain stimulation (DBS)** are used selectively for refractory mood and movement disorders; investigational for others.
• **Esketamine** (intranasal) and off-label ketamine provide rapid-acting antidepressant effects under monitoring protocols.
• **Light therapy** and **chronotherapy** target circadian mechanisms for seasonal and bipolar depression.

Psychosocial and community interventions

Housing support, supported employment/education, peer services, trauma-informed care, and **assertive community treatment (ACT)** reduce hospitalisations and improve functioning. Integrated dual-diagnosis care addresses co-occurring substance use. **Collaborative care** in primary care combines case management, measurement-based care, and psychiatric consultation, improving outcomes and access.

Subspecialties

• **Child and adolescent psychiatry**: neurodevelopmental disorders, mood/anxiety in youth, family and school systems.
• **Geriatric psychiatry**: dementia, late-life depression, polypharmacy, capacity.
• **Addiction psychiatry**: alcohol, opioid, stimulant, and behavioural addictions; medications for opioid use disorder; harm reduction.
• **Forensic psychiatry**: intersections of mental health and the law—competency, criminal responsibility, risk assessment, correctional care.
• **Consultation–liaison (psychosomatic) psychiatry**: psychiatric care in medical/surgical settings; delirium, capacity, transplant, oncology.
• **Emergency psychiatry**: acute agitation, suicidality, intoxication, rapid triage and stabilisation.
• **Neuropsychiatry**: brain–behaviour relationships, functional neurological disorder, post-stroke syndromes, epilepsy.
• **Perinatal/reproductive psychiatry**: mood/anxiety in pregnancy/postpartum, medication management.
• **Sleep and pain psychiatry**: behavioural sleep medicine, chronic pain comorbidity.
• **Community and public psychiatry**: systems of care, homelessness, policy, and population interventions.

Settings of care

Psychiatrists practice in **outpatient clinics**, **general hospitals**, **specialist mental health units**, **primary care** (collaborative care), **emergency departments**, **schools and universities**, **telepsychiatry**, and **forensic/correctional** environments. Levels of care range from crisis and inpatient stabilisation to partial hospitalisation, intensive outpatient, and community outreach.

Training and credentialing

Curricula vary internationally:

• **United States**: MD/DO → 4-year ACGME residency (inpatient, outpatient, C-L, emergency, neurology) → optional fellowships; board certification via ABPN with periodic maintenance.
• **United Kingdom**: medical degree → Foundation Programme → Core Psychiatry Training (CT1–CT3) with MRCPsych exams → Specialty Training (ST4–ST6) → CCT; regulated by GMC and Royal College of Psychiatrists.
• **European Union**: 4–6 years of training per country under UEMS frameworks.
• **Commonwealth and other regions**: analogous structures (e.g., Royal Australian and New Zealand College of Psychiatrists; India’s MD Psychiatry).

Interprofessional teams (psychologists, nurses, social workers, occupational therapists, peer specialists) are central to high-quality care.

Ethics, human rights, and law

Core ethical principles—autonomy, beneficence, non-maleficence, and justice—guide practice. Recurrent issues include **capacity and consent**, **confidentiality**, **seclusion and restraint**, **involuntary admission/treatment** under mental health laws, dual-agency conflicts in forensic settings, and structural inequities in access and outcomes. Human-rights frameworks (e.g., the UN Convention on the Rights of Persons with Disabilities) and recovery movements emphasise supported decision-making and least-restrictive alternatives.

Public health and prevention

Prevention targets **modifiable risks**: perinatal health, child maltreatment, bullying, poverty and housing instability, substance use, and traumatic exposure. School-based and workplace programmes, early psychosis services, suicide prevention (means restriction, post-attempt follow-up), and digital mental health supports are active areas of psychiatric public health.

Research methods and directions

Psychiatric research spans:

• **Clinical trials and comparative effectiveness** (medications, psychotherapies, neuromodulation).
• **Epidemiology and health-services** (access, quality, implementation science, real-world outcomes).
• **Neuroscience and genetics** (GWAS, endophenotypes, circuit models).
• **Computational psychiatry** (reinforcement learning, predictive coding, digital phenotyping).
• **Cultural and social psychiatry** (explanatory models, stigma, migration, structural determinants).

Open science, preregistration, and reproducible pipelines address replication and reporting biases.

Controversies and critiques

Long-standing debates concern:

• **Validity of categories** vs. dimensional/transdiagnostic models; heterogeneity within diagnoses.
• **Medicalisation and overdiagnosis** vs. unmet need and under-treatment, especially in low-resource settings.
• **Pharmaceutical influences** vs. independent evidence and shared decision-making.
• **Coercion and rights** vs. duty of care and safety.
• **Cross-cultural applicability** of Western nosologies vs. local idioms of distress and indigenous healing.

These critiques have spurred reforms in ethics, transparency, service design, and person-centred care.

Representative timeline

Year	Milestone	Significance
c. 1790–1830	Moral treatment (Pinel, Tuke)	Humane care and structured milieu
1880s–1910s	Kraepelinian nosology; psychoanalysis	Course-based classification; psychotherapy
1930s–1950s	ECT; early somatic therapies	Effective intervention for severe illness
1950s–1960s	Chlorpromazine, imipramine, lithium	Psychopharmacology era; deinstitutionalisation
1980	DSM-III operational criteria	Reliability focus; research alignment
1990s–2000s	Imaging/genetics; evidence-based psychotherapy	Mechanistic and outcomes advances
2013–2022	DSM-5 → DSM-5-TR; ICD-11	Harmonisation; dimensional specifiers
2010s–present	Collaborative care; neuromodulation; computational psychiatry	Integrated, person-centred, data-driven care

Comparison with related fields

Field	Training base	Focus	Overlaps with Psychiatry
Clinical psychology	Doctoral psychology (PhD/PsyD)	Assessment and psychotherapy; research	Psychotherapy; testing; health psychology
Neurology	Medicine	Diseases of nervous system; localisation	Neuropsychiatry; dementia; epilepsy; movement disorders
Primary care	Medicine	Common mental disorders in general practice	Depression/anxiety; collaborative care; prescribing
Social work	Social sciences	Social determinants, case management	Psychosocial support; systems of care
Nursing (mental health/psychiatric)	Nursing	Inpatient/community care; advanced practice	Medication management (APRN); psychotherapy; triage

Glossary

Capacity

A person’s ability to understand, appreciate, and reason about information relevant to a decision and to express a choice.

Delirium

Acute, fluctuating disturbance in attention and awareness due to a medical condition or substance.

Insight

Awareness and understanding of one’s mental health condition.

Psychosis

Loss of contact with reality, with hallucinations, delusions, and disorganised thinking/behaviour.

Recovery

A person-centred, strengths-based process of living a satisfying life with or without ongoing symptoms.

Stigma

Social devaluation and discrimination associated with a condition or identity.

See also

• Mental health
• Clinical psychology
• Psychotherapy
• Psychopharmacology
• Neuropsychiatry
• Forensic psychiatry
• Addiction psychiatry
• Child and adolescent psychiatry
• Geriatric psychiatry
• Community mental health services

Further reading

• Kaplan & Sadock's Comprehensive Textbook of Psychiatry (11th ed.), Wolters Kluwer, 2023
• Gabbard's Treatments of Psychiatric Disorders (5th ed.), American Psychiatric Publishing, 2014
• Brave New Brain: Conquering Mental Illness in the Era of the Genome, Oxford University Press, 2001
• Global mental health and sustainable development, The Lancet Psychiatry, 2018
• The Science of the Art of Psychotherapy, Norton, 2012
• The Genealogy of Madness, Oxford University Press, 2011

External links

• American Psychiatric Association
• Royal College of Psychiatrists (UK)
• World Psychiatric Association
• National Institute of Mental Health (NIMH)
• World Health Organization — Mental health
• Mental Health Innovation Network
• The Lancet Psychiatry
• JAMA Psychiatry
• The British Journal of Psychiatry
• National Institute for Health and Care Excellence — Mental health guidance

|}